A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.

The present invention relates to a reabsorbable device for the reconstruction of cartilage and/or bone parts comprising PGA granules.

An adaptor for coupling with a medical container, including: a tubular body receiving a pierceable elastomeric piece, defining an inner cavity of the adaptor, the pierceable elastomeric piece being movable within the tubular body between a first position, in which a distal part of the pierceable elastomeric piece forms a seal of the cavity, and a second position, proximally spaced from the first position, in which the distal part opens the seal of the cavity, an air inlet, a filtering system for filling the inner cavity with decontaminated air, and a gripping member for securing the adaptor to the medical container. Also, an assembly comprising such an adaptor and a medical container.

The disclosure relates to a device and method for tracking status of sterilization for a sterilized package being sterilized in a sterilizer. The method comprises executing instructions on a or at a computing device that: track in a database a status of a first sterilization test relating to the sterilized package being sterilized in the sterilizer; track in the database a status of a second sterilization test relating to the sterilized package being sterilized in the sterilizer; generate on a display controlled by the computing device a graphical user interface (GUI) showing the status of the first and second sterilization tests; and upon a change of the status of the first sterilization test in the database, update the GUI to show an updated status of the first biological test.

An adaptor for coupling with a medical container, including: a tubular body receiving a pierceable elastomeric piece, defining an inner cavity of the adaptor, the pierceable elastomeric piece being movable within the tubular body between a first position, in which a distal part of the pierceable elastomeric piece forms a seal of the cavity, and a second position, proximally spaced from the first position, in which the distal part opens the seal of the cavity, an air inlet, a filtering system for filling the inner cavity with decontaminated air, and a gripping member for securing the adaptor to the medical container. Also, an assembly comprising such an adaptor and a medical container.

A medicament delivery device comprises a housing containing a medicament delivery mechanism including an injection needle. A sterilizing mechanism is connected to the housing. An adhesive surface provides for securing the housing to a patient's skin during a medicament delivery process. The sterilizing mechanism is configured such that, in use once the housing is secured to a patient's skin, the sterilizing mechanism can be operated to sterilize an area of the patient's skin to serve as an injection site.

A beeswax and/or beehive or bee keeping equipment surface is treated with a composition containing at least one solvent, at least one surfactant and at least one oxidizing agent (e.g., peroxide), optionally also containing other components such as an oxidizing agent activator, a viscosifying agent, an enzyme and/or a pH control agent, to reduce the amount of pesticide residues on the beeswax surface and/or disinfect against any bacterial, viruses, and fungi infestation.

In one embodiment, the present application relates to methods and materials for weed control of a field of a crop plant using a cellulose biosynthesis inhibitor selected from the group consisting of ES20 and ES20-1 to ES20-9 of FIG. 1A. In another embodiment, the present disclosure relates to a method for treatment or prevention of an infection through inhibition of biofilm formation of microorganisms comprising the step of applying a therapeutic effective amount of a cellulose biosynthesis inhibitor selected from the group consisting of ES20 and ES20-1?ES20-9 of FIG. 1A, or a salt thereof, in combination with one or more other commonly used antibiotics. A composition matter comprising said compounds and methods of use are within the scope of the present invention.

In one embodiment, the present application relates to methods and materials for weed control of a field of a crop plant using a cellulose biosynthesis inhibitor selected from the group consisting of ES20 and ES20-1 to ES20-9 of FIG. 1A. In another embodiment, the present disclosure relates to a method for treatment or prevention of an infection through inhibition of biofilm formation of microorganisms comprising the step of applying a therapeutic effective amount of a cellulose biosynthesis inhibitor selected from the group consisting of ES20 and ES20-1?ES20-9 of FIG. 1A, or a salt thereof, in combination with one or more other commonly used antibiotics. A composition matter comprising said compounds and methods of use are within the scope of the present invention.

A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.